MAOA

MAOA Overview

English Name	Monoamine oxidase A	Approved Drugs	2
Drugs in Clinical Trials	1	Target Synonym	EC 1.4.3，EC:1.4.3.4，Monoamine oxidase type A，Amine Oxidase [Flavin-Containing] A，MAO-A，MAOA，Monoamine Oxidase A，EC 1.4.3.4，BRNRS
Highest Development Stage	Approved

English Name	Monoamine oxidase A
Target Synonym	EC 1.4.3，EC:1.4.3.4，Monoamine oxidase type A，Amine Oxidase [Flavin-Containing] A，MAO-A，MAOA，Monoamine Oxidase A，EC 1.4.3.4，BRNRS
Approved Drugs	2
Drugs in Clinical Trials	1
Highest Development Stage	Approved

MAOA Product List

Product Category
Protein (1)
Product Status
Launched (1)
Species
Human (1)
Tag
His Tag (1)
Conjugate
Unconjugated (1)

Cat. No.	Species	Host	Product Description	Structure	Purity	Feature	Order Now
MAA-H5547	Human	InsectCells	Human MAOA Protein, His Tag, low endotoxin (active enzyme)				Add to Cart

Total: 1

MAOA Background

MAOA, Monoamine oxidase-A is an FAD-dependent mitochondrial enzyme, which, together with its isoenzyme MAO-B, catalyses the oxidative deamination of structurally diverse amines. MAOA is mainly involved in the metabolism of monoamine neurotransmitters, such as such as serotonin, dopamine, and norepinephrine. Inhibitors of MAOA are in clinical use for affective disorders and is approved to treat despression.

MAOA Synonyms

MAOA

Clinical Drug Information

English Name	Research Code	Highest Development Stage	Company	Indication	Clinical Trial
CB-2202	CB-2202	Phase 2 Clinical	Cennerv Pharma	Depressive Disorder, Major	Details

Marketed Drug Information

English Name	Research Code	Highest Development Stage	Company	Earliest Brand Name	Earliest Approval Country	Earliest Indication	Earliest Approval Company	Earliest Approval Date	Indication	Clinical Trial
Toloxatone	MD-69276	Approved		Umoril, Humoryl, Perenum	France	Depression	null	1984-01-01	Depression	Details
Metaxalone (Primus Pharmaceuticals)		Approved	Primus Pharmaceuticals Inc		United States	Muscle Spasticity	Primus Pharmaceuticals Inc	2015-06-01	Muscle Spasticity	Details